Trial intelligence / Profile preview

Phase III randomized double-blind trial of adjuvanted vs non-adjuvanted AC meningococcal + Hib conjugate vaccine in 2–3 month-old infants

CTR20191651Phase 3Completed

Sponsor
Zhifei Green Bamboo
Start
Aug 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of meningococcal group A and C and haemophilus type b conjugate vaccine in meningococcal disease, Haemophilus influenzae type b disease (Hib), bacterial meningitis, bacterial pneumonia, sepsis, sponsored by Zhifei Green Bamboo. Started Aug 2019; status: completed.

02

Drugs

meningococcal group A and C and haemophilus type b conjugate vaccine
03

Conditions

meningococcal diseaseHaemophilus influenzae type b disease (Hib)bacterial meningitisbacterial pneumoniasepsis

Beyond the preview

Go deeper on CTR20191651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20191651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call